Skip to NavigationSkip to content

News

0
google logo
French firm teams up with Google's life sciences division to develop tools for patients and clinicians
0
Alexion sign
European Commission signs-off two of the firm’s enzyme replacement therapies
0
US firm could pay up to $1.25 billion for rights to Promedior’s pipeline drug, and signs immuno-oncology research agreement with Australian group
0
FDA sign
US regulator says class of diabetes drugs can cause ‘severe and disabling pain’

Features

scales

Professor Sam Salek explains why it is time for a universal template for better decision-making in the pharma industry